Late-Breaking Data at EADV of ESK-001, an Oral TYK2 Inhibitor for the Treatment of Psoriasis, Demonstrate Significant Responses with Sustained Increases Over 28 Weeks in Phase 2 OLE Study
| ALMS Stock | 8.04 0.33 3.94% |
Slightly above 54% of Alumis Common's investor base is interested to short. The analysis of the overall investor sentiment regarding Alumis Common Stock suggests that many traders are impartial. Alumis Common's investing sentiment can be driven by a variety of factors including economic data, Alumis Common's earnings reports, geopolitical events, and overall market trends.
Alumis |
28-week data show ESK-001 was generally well tolerated and most patients treated with the top dose of 40 mg twice daily achieved PASI 75Three additional data presentations further support ESK-001s potential to offer a highly differentiated and best-in-class treatment profile for people with moderate-to-severe plaque psoriasisFull 52-week Phase 2 OLE dataset expected 1H 2025 Phase 3 clinical program ongoing SOUTH SAN FRANCISCO, Calif., Sept. 27, 2024 -- Alumis Inc. Nasdaq ALM
Read at finance.yahoo.com
 |
Alumis Common Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Alumis Common can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Alumis Common Fundamental Analysis
We analyze Alumis Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alumis Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alumis Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Alumis Common is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Alumis Common Stock Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alumis Common stock to make a market-neutral strategy. Peer analysis of Alumis Common could also be used in its relative valuation, which is a method of valuing Alumis Common by comparing valuation metrics with similar companies.
Peers
Alumis Common Related Equities
| HOOK | Hookipa Pharma | 0.00 |
| ||
| KPTI | Karyopharm Therapeutics | 0.83 |
| ||
| FATE | Fate Therapeutics | 1.19 |
| ||
| CRBU | Caribou Biosciences | 5.59 |
|
Additional Tools for Alumis Stock Analysis
When running Alumis Common's price analysis, check to measure Alumis Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alumis Common is operating at the current time. Most of Alumis Common's value examination focuses on studying past and present price action to predict the probability of Alumis Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alumis Common's price. Additionally, you may evaluate how the addition of Alumis Common to your portfolios can decrease your overall portfolio volatility.